Introduction: It has not been previously investigated whether the recurrence mechanism
| INTRODUCTION
Numerous important advances have been achieved in the past decade in catheter ablation of paroxysmal atrial fibrillation (AF).
Radiofrequency catheter ablation (RFCA) of AF has been one of the therapies since the reports from Haïssaguerre et al 1 and Chen et al. 2 Complete isolation of all pulmonary veins (PVs) is the cornerstone and established endpoint of AF ablation. 3, 4 With the application of three-dimensional (3D) electroanatomical mapping, open-irrigated catheter, and contact force guidance, the success of radiofrequency (RF) ablation has increased. 5, 6 However, the complexity of RF ablation technology and the pointby-point technique demands extensive training. The balloon-based technology can isolate each PV with one or two applications. The safety and efficacy of cryoballoon ablation (CBA) for PV in patients with symptomatic paroxysmal AF were first reported by Packer et al. 7 Recently, the FIRE and ICE trials demonstrated comparable safety and efficacy of CBA and RFCA in the primary endpoint, but secondary analyses revealed fewer rehospitalizations and repeated procedures in patients undergoing CBA rather than RFCA. 8 Up to 35% of patients in the FIRE and ICE trials undergoing CBA for paroxysmal AF met the primary efficacy endpoint, including recurrence of AF lasting more than 30 seconds, documented occurrence of atrial flutter or atrial tachycardia, prescription of antiarrhythmic drugs (class I or III), or repeat ablation. However, there are few studies evaluating the recurrent patterns after CBA.
We conducted a retrospective study to analyze the differences between the outcome and recurrent patterns between CBA and RFCA after ablation of paroxysmal AF.
| MATERIALS AND METHODS

| Patient population
A total of 210 patients with symptomatic and drug refractory paroxysmal AF referred to Taipei Veterans General Hospital for electrophysiology study and ablation were enrolled from 2014 to 2016, retrospectively. Of that cohort, 69 patients in the CBA group and 69 in the RFCA group were matched in a 1:1 ratio based on propensity scores, which resulted in two balanced groups. Paroxysmal AF was defined according to the statement from the 2017
Heart Rhythm Society Expert Consensus. 3 All clinical data were obtained after the approval from the Taipei Veterans General
Hospital Institutional Review Board (IRB number: 2017-03-011BC), and baseline characteristics were assessed in detail.
| Electrophysiological study and ablation procedure
The details have been described in our previous study. 9 Briefly, after providing written informed consent, each patient underwent an electrophysiological study and ablation while in the fasting nonsedated state. All antiarrhythmic drugs except for amiodarone were withdrawn for at least five half-lives before the electrophysiological study and ablation procedure. Local anesthesia was used in all ablation procedures. In patients presenting to the lab with sinus rhythm, we did try to induce AF with burst atrial pacing or infusion of isoproterenol (up to 4 μg/min).
| CBA procedure
After left atrial (LA) access had been achieved, activated clotting time was maintained over 250 seconds by supplementing heparin infusion as required. In the CBA, an exchange wire was kept within the left superior PV, and a steerable 15-F over-the-wire sheath Bidirectional conduction block of the CTI was confirmed after restoration to sinus rhythm. 
| RFCA procedure
| Non-PV triggers and LA flutter ablation
For mapping of non-PV triggers, 13 we evaluated the activation In patients with other non-PV AF triggers, catheter ablation was performed in the area with the earliest electrical activity or a local unipolar QS pattern of the ectopic beats preceding AF. 14 An irrigated ablation catheter with a target temperature of 35 to 40°C and maximum power of 25 to 35 W was used.
If LA flutter was induced and sustained for more than 1 minute, the reentry circuit of an LA flutter was identified by activation mapping, entrainment maneuvers, and postpacing interval analysis. 15 Ablation was guided by the 3D mapping system, and RF energy was 
| Repeat ablation procedures
Patients underwent a repeat procedure if drug-refractory symptomatic recurrence of sustained atrial tachyarrhythmia was recorded.
RFCA was performed in all patients. During repeat procedures, we applied the same steps as mentioned above with identification of non-PV triggers, targeting atypical flutter and isolation of reconnected PV. The follow-up scheme and recurrence detection methods were the same as that after the index procedure.
| Statistical analysis
All continuous variables were reported as mean ± standard deviation (SD), while categorical variables were reported as proportions.
Between-group comparisons of continuous variables were performed using Student's t test. A univariate analysis of the various clinical variables was performed to evaluate differences between the two groups before the first procedure. The variables selected for testing in the multivariate analysis were those with a P < 0.1 in the univariate models. A two-sided P < 0.05 was considered significant. All statistical analyses were performed using SPSS software version 20.0 (SPSS Inc, Chicago, IL).
3 | RESULTS
| Patient baseline characteristics
Among the 138 patients enrolled in this study, 69 underwent CBA and 69 underwent RFCA. The baseline characteristics and demographics of the matched patients are shown in Table 1 , and the RFCA/CBA time of each PV, procedure/fluoroscopy times, complications, and antiarrhythmic drugs after the procedure are presented in Table 1 .
| Acute outcome after first ablation of AF
During AF ablation, isolation of all major PVs was achieved in 67 (97.1%) patients in the CBA group and 65 (94.2%) in the RFCA group.
In the first procedure, non-PV triggers were identified in 9 (13%) patients in the CBA group and 10 (14.5%) patients in the RFCA group (P = NS; not reveal difference in recurrence (log-rank P = 0.141) between groups ( Figure 1A ). Eleven of (68.9) 16% patients with recurrence in the CBA group and 16 (84.2%) out of 19 patients in the RFCA group underwent repeat ablations, and recurrent patterns were confirmed during the repeat procedure. In univariate analysis of all patients, older age, high CHA2DS2-VASc score, and CBA group were related to non-PV recurrence, and multivariant Cox regression analysis indicated that age and CBA were both independent predictors of non-PV recurrence after ablation of paroxysmal AF (Table 2 ).
| Patterns and predictors of recurrent atrial arrhythmia during the repeat procedure
The repeat procedure revealed PV reconnection in 81.8% in the CBA group and 93.8% in the RFCA group (P = NS), and the distributions of the reconnected PV were similar between both groups (Table 3 ). In those who had undergone a repeat procedure, there was no difference in the mean LA voltage between groups during the first procedure. In comparison with the RFCA group, the CBA group had a lower mean LA voltage (P = 0.027) and larger scar areas (P = 0.01) during the repeat procedure (Table 3) . Moreover, the distribution of the LA low voltage area in the CBA group was also more extensive than that in the RFCA group, especially in the lateral and posterior walls (Figure 2 ).
Regarding non-PV triggers during the repeat procedure, patients in the CBA group had more non-PV triggers (P = 0.009) and LA macroreentrant flutters (P = 0.027) during the repeat procedures (Table 3 ). The locations of non-PV triggers during the repeat procedure were not related to those during the first procedure. LA macroreentrant flutters including roof-dependent, septal, and peri- 
Abbreviations: AAD, antiarrhythmic drug; BMI, body mass index; CAD, coronary artery disease; CBA, cryoballoon ablation; CHF, congestive heart failure; CI, confidence interval; LA, left atrial; LVEF, left ventricular ejection fraction; NS, no significance; PV, pulmonary vein; RFCA, radiofrequency catheter ablation.
length of the mitral isthmus with a bipolar voltage of more than 0.5 mV was significantly shorter in patients with mitral flutter than in those without mitral flutter (7.4 ± 1.7 vs 13.6 ± 3.7 mm; P = 0.035), and the distribution of the scar and low voltage zone (bipolar voltage <0.5 mV) was mostly extended from the bottom of LIPV to the upper mitral isthmus. Figures 3 and 4 present examples of LA roof and perimitral flutter in patients during the second procedure. Figure 1B shows the recurrence after the last procedure with a mean follow-up of 10.7 ± 6 months, and the Kaplan-Meier curve did not reveal a significant difference (log-rank P = 0.167) between the two groups.
4 | DISCUSSION
| Main findings
The main findings of this study were as follows: (1) There was no significant difference in recurrent atrial arrhythmia between CBA and RFCA after ablation of paroxysmal AF in Asian patients. (2) In the repeat procedure, incidence, and distributions of PV reconnection were similar between both groups. However, the CBA group had more non-PV triggers and LA flutter than the RFCA group. (3) Age and CBA were both independent predictors of non-PV recurrence after ablation of paroxysmal AF. These findings implied different mechanisms of recurrent atrial arrhythmia between CBA and RFCA of paroxysmal AF.
| Mechanisms of recurrent atrial arrhythmia after RFCA or CBA of AF
Since RFCA has become a potentially curative option for AF, studies have reported that PV reconnection is the main cause of recurrent atrial arrhythmia, and our results are in line with previous studies. [16] [17] [18] During the repeat procedure, 81.8% of the CBA group and 93.8% of the RFCA group had PV reconnection. CBA is one of the technologies for PV isolation, which has been widely adopted for the treatment of patients with paroxysmal AF. Nevertheless, there were few studies regarding the mechanism of recurrent atrial arrhythmia after CBA. Our results demonstrated that PV reconnection still remained a major cause of recurrence during a second procedure.
T A B L E 3 Characteristics of LA substrate and recurrent patterns of atrial arrhythmia in patients receiving repeat ablation procedure CBA group, n = 11 RFCA group, n = 16 P value results implied that CBA paved the way for a different path for atrial debulking and scar formation.
| STUDY LIMITATIONS
First, this was a retrospective study and enrolled a relatively small patient population, so it was difficult to collect a large number of patients, who underwent a repeat procedure. Second, it was difficult to evaluate the asymptomatic episodes of AF, even when using a regular Holter monitor or the cardiac event recorders recommended by the 2017 heart rhythm society (HRS) expert consensus. 3 Thus, this is a universal limitation for the asymptomatic episodes. Finally, some patients were followed with 24-h Holter monitoring, and others were followed with 1-week recordings of a cardiac event recorder. The inconsistent electrocardiography monitoring during follow-up might impact the recurrence. In this study, we followed the patients regularly in the clinics and evaluated the symptoms of patients.
| CONCLUSION
In patients with paroxysmal AF, there was no difference in recurrent Tze-Fan Chao http://orcid.org/0000-0002-6587-3094
